Annual report pursuant to Section 13 and 15(d)

Business and Summary of Significant Accounting Policies (Details Narrative)

v3.23.1
Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Net loss $ 1,548,000 $ 1,420,000  
Cash flow from operations 923,000 722,000  
Stockholders' deficit 4,690,000 4,173,000 $ 3,507,000
Notes payable 1,730,000    
Cash on Hand 133,000 114,000  
Asset impairment 0 0  
Research and development costs $ 486,000 $ 350,000  
Stock Options [Member]      
Antidilutive shares 26,057,601 31,080,601  
Warrants [Member]      
Antidilutive shares 20,314,153 19,977,149  
Convertible Notes [Member]      
Antidilutive shares 35,138,466 24,100,887  
Patent Costs [Member]      
Operating expenses $ 13,000 $ 20,000